The BRCT region, the carboxyl-terminus of BRCA1 (the breast cancer susceptibility gene 1 product), is a ubiquitous region homologous to regions in DNA repair enzymes and cell cycle regulators. We showed that the BRCT regions bound DNA fragments, using the TopBP1 protein (topoisomerase II binding protein 1), with eight BRCTs as a model protein. The bindings were independent of DNA sequences, forms of DNA termini and energy. The BRCT-DNA complex showed resistance to an exonuclease, indicating that BRCT bound DNA breaks. The BRCTs also bound DNA nicks, suggesting that BRCTs play an important role in detection of both single-and double-strand DNA breaks or ends. On the other hand, BRCTs did not bind circular intact DNA. BRCTs of BRCA1 also bound DNA termini. Since some BRCTs are unique general elements in some tumor suppressions, these ®ndings will reveal novel aspects of the tumor suppression mechanism.
Introduction
Defects in the DNA repair system occasionally cause serious dangers of oncogenesis. The tumor suppressor BRCA1 (the breast cancer susceptibility gene 1 product), is suggested to play a role in DNA repair. BRCA1 (Miki et al., 1994) possesses two repeating motifs, the BRCT (BRCA1 carboxyl-terminus) regions (Koonin et al., 1996) , which are ubiquitous in proteins involved in DNA repair and cell cycle (for example, Cut5, Ect2, Rad9 and XRCC1 proteins) (Bork et al., 1997; Callebaut and Mornon, 1997) . BRCA1 interacts with Rad51 participating in DNA repair and recombination (Scully et al., 1997b) , and is phosphorylated and localized at replicating sites of DNA after DNA damage (Scully et al., 1997a) . Although indirect evidence suggests involvement in DNA repair, biological roles of BRCA1 and BRCT are poorly understood.
Some BRCT regions are unique general elements in the phenomenon of tumor suppression as follows: (a) truncation of the amino-terminal BRCT region of the Ect2 proto-oncoprotein induced its transforming activity (Miki et al., 1993) ; (b) some familial mutations of BRCA1 fell into the BRCT regions that inhibited growth of yeast (Humphrey et al., 1997) ; (c) the retinoblastoma susceptibility protein (Rb) family also contains a BRCT-related region (Bork et al., 1997) ; (d) the 53BP1 protein with two BRCTs is the unique p53-binding protein that selectively binds the wild-type p53 tumor suppressor, notably with its BRCTs (Thukral et al., 1994) ; (e) additionally, the excised ®rst BRCT region of Cut5 with four BRCTs had a negative eect on entry into mitosis (Saka et al., 1994) . Thus, elucidating the unknown function of BRCT will be very important in the analysis of the tumor suppression mechanism.
We have identi®ed a novel DNA topoisomerase II binding protein, TopBP1 interacting with the carboxylterminal region of topoisomerase IIb (Yamane et al., 1997) , using a two-hybrid system (Gyuris et al., 1993) . TopBP1 possessed eight BRCT regions, three BRCTrelated regions and a region homologous to automodi®cation sites of poly(ADP-ribose) polymerase. Since TopBP1 is similar to the DNA repair and checkpoint proteins, TopBP1 is speculated to participate in DNA repair and cell cycle regulation caused by failure of catalytic reactions of topoisomerase II through DNA strand breaks. The in vivo binding of TopBP1 to the topoisomerase remains to be con®rmed since it is immediately degraded after lysis of the cell, suggesting that the topoisomerase binding is partly putative. We used TopBP1 as a model protein with BRCTs, independent of the topoisomerase binding. Judging from its high homology with Cut5, TopBP1 will have other important binding partners (Discussion).
We noted that DNA ligases III, IV and terminal deoxynucleotidyltransferase with BRCT(s) participate in catalytic reactions associated with DNA breaks. The XRCC1 protein with two BRCTs plays a role in singlestrand DNA break repair (Shen et al., 1998) . TopBP1 may also participate in DNA repair. Taken together, this information forms the basis of our hypothesis that the BRCT region recognizes DNA damage and directly binds DNA breaks and ends. This hypothesis is shown to be true in this report using the TopBP1 protein and the BRCA1 protein.
Results
The B1 BRCT region of TopBP1 can bind DNA fragments To examine whether BRCT regions can bind DNA, the B1 BRCT region (Figure 1a ) of TopBP1 was synthesized in E. coli as a GST (glutathione Stransferase) fusion. The GST-B1 was ®xed and puri®ed on glutathione-sepharose beads (Figure 1b , lane 2). The ®xed proteins were incubated with 32 Plabeled DNA oligomers (Figure 2a ), and washed with the buer. The bound DNAs were eluted with proteinase K digestion, and analysed with nondenaturing gel electrophoresis. The GST-B1 BRCT region bound the D1 oligomers ( Figure 2b , lane 6). B1 also bound DNA oligomers with a nick, partially annealed DNA and a single-stranded DNA (lanes 7 ± 10).
Binding is independent of DNA sequences and energy
The DNA fragments of pUC19 digested with MspI were subjected to the DNA binding assay (Figure 3a , Fixed). The B1 and B6-78- (Figure 1 ) proteins bound any pUC19 fragments (Figure 3a, lanes 3 and 4) . The bindings of the BRCT region to DNA were not sequence speci®c since the BRCT regions bound the arti®cial model DNA fragments in Figure 2 and any pUC19 fragments digested with MspI. Negative controls, C1 and C2 that did not contain BRCT regions did not show any DNA binding activity (lanes 5 and 6). Further, B1del that was deleted the Cterminal Trp residue conserved in many BRCT regions showed the strongly reduced activity (lane 7).
The B1 and B6-78-BRCT protein eluted from the beads inhibited the migration of DNA fragments (Figure 3a , lanes 10 and 11). There were smear shifted bands, and the major labels were detected at the top of the gel, indicating that the DNA-BRCT complex was partly very large. The three negative controls did not show the retardation activity (lanes 12 ± 14). It should be noted that general gel retardation assay using short nucleotides may fail to detect the activity, since B1 only partially shifted the 67 bp band (lane 10) and did not shift it in lower B1 concentration. On the other hand, the DNA binding assay used in this report showed higher sensitivity.
Adding of 5 mM EDTA did not inhibit binding ( Figure 3b , lane 2). Replacement with the buer that did not contain common solutes did not inhibit binding (lane 3), indicating a low requirement for speci®c buer conditions. Adding of 1 mM ATP, GTP, CTP and UTP did not stimulate binding (lane 6). The optimum binding was observed in 0 ± 100 mM NaCl (lanes 7 ± 11).
Other BRCT regions also bind DNA fragments
We ligated D1 nucleotides used in Figure 2a that were phosphorylated at the 5' end in both strands. The B1 Figure 1 Structures of TopBP1 and GST-BRCT fusions, and expression of the fusions. (a) Hatched boxes 1 ± 8 are the BRCT regions. Numbers at each end of boxes indicate amino acid residue numbers at amino-and carboxyl-terminus of each construct. (b) GST-BRCT fusions were induced in E. coli and were ®xed and puri®ed on glutathione-sepharose beads. Proteins were eluted by adding of gel loading buer containing SDS (Laemmli, 1970) and boiling. Polyacrylamide (5 ± 20%) gradient gel electrophoresis was performed (Laemmli, 1970) , and the gel was stained with Coomassie blue. The expressions were various in amount The ®xed GST-B1 or GST proteins were incubated with the indicated labeled oligomers (D1-D5, 61 pmol), washed with the buer, and then bound DNAs were eluted by proteinase K digestion (the binding assay). The bound oligonucleotides were analysed with nondenaturing gel electrophoresis (7% polyacrylamide, 0.24% N, N'-methylenebisacrylamide). The loaded DNA in the input lanes was 1.0% of the DNA added into the binding assay region bound dimers and higher polymers more strongly than it bound monomer DNA ( Figure 4a , lane 3). Other regions, B6-78-, B12, B6 and B7, in Figure 1b , also bound ligated D1 with dierent intensities (Figure 4a , lanes 4 ± 7). To introduce arti®cial single-strand breaks on DNA, only the upper strand of D1 in Figure 2a was 5' phosphorylated, annealed with unphosphorylated lower DNA, and ligated. The binding patterns of BRCTs to nicked DNAs were similar to those for DNAs without arti®cial nicks (Figure 4b ). The nick binding of BRCT without the eect of double-strand breaks will be examined further in the next section.
BRCTs also bind linearized long DNA and circular DNA with nicks
The B1 and B6-78-bound linearized DNA of pUC19, composed of 2686 base pairs (Figure 5a , lanes 5 ± 12). The bindings were independent of the terminal forms created by restriction enzymes, SmaI (blunt), PstI (3' protruding) and BamHI (5' protruding, data not shown). The eciency of binding to circular DNA from the same preparation was signi®cantly low (lanes 3 ± 4), indicating that binding to linear DNA was not non-speci®c aggregation. To introduce single-strand breaks onto a circular DNA, we boiled a mixture of two kinds of DNA that were linearized with two distant, unique sites. After annealing, the portion formed circular DNAs with nicks ( Figure 5b and c, lane 3). This mixture was subjected to the binding assay. The input pattern was similar to that of the binding fractions (lanes 5 ± 8), indicating that the BRCTs bound both the linearized and the circular DNA with nicks to the same degree.
Only unlabeled DNA with breaks titrates binding to labeled DNA
We performed the binding assay with a series of diluted, unlabeled DNA (Figure 6a ). Unlabeled pUC19 DNA, linearized with the unique site SmaI, inhibited Figure 3 Binding is independent of DNA sequences. (a) The DNA fragments of pUC19 digested with MspI (20 pg) (input) were labeled and subjected to the DNA binding assay. The GST-BRCT fusions ®xed on beads were subjected to the binding assay (Fixed). The GST-BRCT fusions eluted from beads were incubated with the DNA (Eluted), and directly applied on the non-denaturing gel. (b) The GST-B1 BRCT fusion ®xed on beads were prewashed twice with speci®c buers, incubated with DNA digested with HinfI (lanes 1 ± 6) and with MspI (lanes 7 ± 11) and washed three times with speci®c buers in the binding assay. The speci®c buers were 10 mM Tris-HCl, pH 7.7, 0.5% Nonidet P40 and indicated salts, EDTA, except that the buer was 10 mM Naphosphate, pH 7.3, 0.5% octyl glucoside in lane 3. Incubation was performed in the presence of 10 mM MgCl 2 (lane 5), 10 mM MgCl 2 and 1 mM 4 NTP (lane 6) Figure 4 Other BRCT regions also bind DNA fragments. The loaded DNA in the input lanes was 40% that of the DNA added into the binding assay (6 pmol of D1). (a) Both phosphorylated strands of D1 in Figure 2a were annealed, self-ligated, dephosphorylated, and then labeled with g-32 P-ATP and T4 polynucleotide kinase. The binding assay was performed with various BRCT regions in Figure 1a and b. (b) The probe was prepared as described in A, except that only the lower strand of D1 in Figure  2a was 5'-phosphorylated before the self-ligation the binding of GST-B1 to labeled DNA digested with SmaI in a dose-dependent manner (approximately 90 to 20%). In contrast, unlabeled circular DNA, a mixture of 96% covalently closed circular DNA and 4% nicked DNA, showed very weak inhibition of the binding of labeled linear DNA (6b). Consistently, labeled circular DNA showed faint binding which was inhibited with unlabeled linear DNA (6b). These results indicated that binding to broken DNA was not non-speci®c aggregation. The binding of labeled linear and circular DNA was titrated with unlabeled circular DNA and with unlabeled linear DNA, respectively. Experiments with labeled circular DNA/unlabeled circular DNA was similar to those of labeled circular DNA/ unlabeled linear DNA, and omitted. Circular DNA used was a mixture of 96% covalently closed circular DNA and 4% nicked DNA. (c). The same experiment in (a) was performed using labeled D1 oligonucleotides (960 intensity, 4.5 fmol) and a series of unlabeled D1 DNA and quanti®ed as described in (b). Total DNA indicated total amounts of labeled DNA and unlabeled DNA
BRCTs inhibit exonuclease digestion of DNA fragments
To examine whether BRCT bound ends of DNA fragments, we used exonuclease digestion. The pUC19 fragments were incubated with puri®ed BRCTs on glutathione beads. The beads were washed (Figure 7a , Bound, lanes 5 ± 7). The free fragments (1.0 ng, lane 4) were added again in GST alone (lane 5) before digestion as a control. These mixtures were then digested with exonuclease BAL31. The fragments resisted digestion in the presence of the GST-B6-78-and GST-B1 regions (Figure 7a, lanes 2 and 3) . These results indicate that, at least, a portion of BRCTs bound the ends of DNA fragments resulting from DNA breaks.
BRCTs form large complexes
We chemically cross-linked eluted, puri®ed GST fusions (Figure 1 ) preincubated in the presence or absence of D1 DNA fragments. The GST-B1 and GST-B6-78-formed cross-linked complexes near the top of the gel, in spite of the absence of the DNA fragments (Figure 7b ). The molecular mass of the complexes was estimated to be more than 480 kDa. This migration of the large complex was consistent with the migration of BRCT-labeled DNA complex at the top of the gel (Figure 3a , lanes 10 and 11).
Native TopBP1 is rapidly degraded after cell lysis
The TopBP1 protein was detected on the Western blot analysis of HeLa cells treated with trichloroacetic acid (Figure 8a , lane 1). The larger band was migrated at 150 kDa, very close to the calculated 160 kDa. The smaller band at 48 kDa may be produced by alternative splicing of the mRNA precursor. The total TopBP1 mRNA contains 12 AUUUA motifs that confer instability of mRNA and was shown to be rapidly degraded (Yamane et al., 1997) . The TopBP1 protein in lystate was almost completely degraded Figure 7 BRCTs inhibit exonuclease digestions of DNA fragments, and BRCTs form large complexes. (a) The HaeIII fragments of pUC19 were incubated with puri®ed GST-BRCTs on glutathione beads. Incubated mixtures were then digested with exonuclease BAL31 digestion. The selected DNA bound to beads were also subjected to BAL31 digestion. The free fragments (1.0 ng, lane 4) were added again into a sample of lane 5 before digestion as a control. (b) Eluted, puri®ed GST fusions (5 mg/ 10 ml) were preincubated in the presence or absence of 3.3 pmol D1 oligomers for 10 min at 378C and incubated with 3 ml of dimethyl suberimidate (Sigma, 18 mg/1 ml of 1 M triethanolamine-HCl, pH 8.5) for 1 h at room temperature (Yamane and Mizushima, 1988) . Samples were subjected to SDS polyacrylamide (5%) gel electrophoresis and were silver-stained Figure 8 Native TopBP1 is rapidly degraded after cell lysis, and DNA fragments do not inhibit TopBP1 binding to topoisomerase II. (a) Western blotting was performed with anti-B-78-antibody or preimmune antiserum. HeLa cells were treated with TCA (trichloroacetic acid) to denature almost proteins (lanes 1, 3 and 5). Alternatively, the cells were washed, trypsinized, and suspended in buer containing several protease inhibitors. The cells were sonicated and the lysate was incubated on ice for 20 min and then treated with TCA (lanes 2, 4 and 6). Total proteins in these samples were also stained with Coomassie blue. (b) The GST fusions (adjusted to 4.5 mg/20 ml of beads) bound to glutathione sepharose beads were preincubated for 10 min at 378C in the presence or absence of unlabeled 10 pmol D1 DNA fragments. The carboxyl-terminal region (amino acid 1143 ± 1621) of topoisomerase IIb was synthesized in vitro in the presence of [ 35 S]methionine and was mixed and incubated with the preincubated GST fusions on beads, as described (Yamane et al., 1997) . The beads were washed and then associated proteins were analysed with gel electrophoresis and an image analyzer during a short incubation on ice, in the presence of several protease inhibitors (lane 2). Discovery of the degradation inhibitors is essential to experiments with the immunopuri®ed whole TopBP1 protein from native cells.
DNA fragments do not inhibit TopBP1 binding to topoisomerase II in vitro
The carboxyl-terminal region of topoisomerase IIb was synthesized in vitro using a rabbit reticulocyte lysate system and was incubated with GST fusions bound to glutathione beads. The beads were washed and then the associated proteins were analysed (Figure 8b) . The carboxyl-terminal region of topoisomerase IIb specifically interacted with B6-78-but not with B6 and B78 (lanes 1 ± 4). Preincubation with DNA fragments did not change the binding patterns (lanes 5 ± 8), indicating that the DNA fragments did not inhibit binding to topoisomerase II. These results suggest that TopBP1 binding to topoisomerase II required the outside region(s) of the B6 and B78 BRCTs, or that the binding required the presence of B6 and B78 on the same polypeptide. The association of TopBP1 with topoisomerase II is reasonable since topoisomerase II often causes DNA breaks upon addition of topoisomerase II-targeting anticancer drugs.
The BRCT region of BRCA1 can bind DNA fragments
To examine whether other BRCT regions can bind DNA, the BRCT regions of BRCA1 (Figure 9a ) fused to GST were synthesized in E. coli. The GST-BRCT was ®xed and puri®ed on glutathione-sepharose beads (Figure 9b ). The ®xed proteins were subjected to the binding assay. The GST-BA12 and GST-BA1 bound any DNA fragments (Figure 9c) . The GST-BA2 showed the faint DNA binding activity. These results indicated that the BRCT regions of BRCA1 also bound DNA fragments in a sequence-independent manner. The minimal requirement of the single BRCT (BA1) for the activity was consistent with those of TopBP1 (B1, B6 and B7 BRCTs). The binding of BA12 was also high salt-sensitive (Figure 9d ). The binding of BA12 did not change in the presence of ATP, GTP, CTP and UTP ( Figure 9e , lane 2). The DNA fragments bound to GST-BA12 ®xed on beads were resistant to the BAL31 exonuclease (Figure 9e, lane 6) . On the other hand, free fragments added to GST alone were not resistant (Figure 9e, lanes 3 and 5) . The resistance did not change in a large 1419 base pair DNA fragment, indicating that the BA12 or BRCA1 bound to the termini of the DNA fragments. These results of BRCT in BRCA1 were similar to that in TopBP1. GST-BRCT fusions were induced in E. coli and were ®xed and puri®ed on glutathione-sepharose beads and analysed as described in the legend to Figure 1b. (c) The ®xed GST and GST fusions (adjusted to 2 mg) were subjected to the binding assay (Figure 2b ), using labeled pUC19 DNA (60 pmol) digested with HinfI. (d) The binding assay of GST-BA12 fusion on beads was performed in the presence of the speci®c buers, that were 10 mM Tris-HCl, pH 7.7, 0.5% Nonidet P40 and indicated concentrations of NaCl. pUC19 DNA digested with HinfI was used. (e) Incubation was performed in the presence of 0.5 mM MgCl 2 (lane 1), 0.5 mM MgCl 2 and 0.1 mM 4 NTP (lane 2). Digestion with BAL31 was performed as described in the legend to Figure 7a . Free DNA fragments were added to GST alone samples before digestion. Deg, degraded DNA Figure 10 Reduction of TopBP1 makes cells ultraviolet sensitive in vivo. Anti-sense (Anti) oligonucleotides against TopBP1, and scrambled control nucleotides (Cont.) were introduced into HeLa cells. After 2 days, cells were weakly exposed to ultraviolet light (10 J/m 2 , 254 nm). Cell survival was determined after 3 days by trypan blue exclusion and expressed as a percentage of unexposed viable cells at 100%
Reduced expression of TopBP1 leads to reduction of viable cells after DNA damage in vivo Anti-sense oligonucleotides against TopBP1 were introduced into HeLa cells. After 2 days, the amount of TopBP1 protein was reduced to 40 to 35% with the oligonucleotides (data not shown). The cells were then weakly treated with ultraviolet light to induce DNA damage. After 3 days, viable cells treated with the antisense nucleotides were reduced to 68% (Figure 10 ), suggesting that TopBP1 protein was required for DNA damage checkpoint in vivo.
Discussion
The key to solve the unknown function of BRCTs was the association of the reaction with DNA breaks in terminal deoxynucleotidyltransferase and the DNA ligases with BRCT(s). We expect that BRCT directly binds DNA breaks, and showed herein that BRCT regions of TopBP1 bound any DNA fragments of the plasmid DNA.
The major features of DNA binding of BRCTs of TopBP1 were that: (1) binding occurred to both singleand double-stranded DNA fragments; (2) binding was independent of sequences; (3) binding to doublestranded DNA was independent of the all forms of the ends tested; (4) binding was energy independent; (5) binding did not require speci®c buers, however (6) binding was high salt sensitive; (7) binding occurred in all BRCT regions tested; (8) binding was stronger to DNA longer than about 70 base pairs, than to DNA of about 35 base pairs; (9) binding conferred the exonuclease-resistance to DNA fragments; (10) binding occurred to the circular DNA with nicks, but not to circular DNA, and (11) binding of B6-78-to topoisomerase II was not inhibited by addition of DNA fragments. As a whole, the low requirement for binding conditions may correlate with emergent responses of life systems to DNA damage.
The Ku protein is a well-characterized DNA endbinding protein (for example, Blier et al., 1993) . Many binding features of Ku are similar to those of TopBP1 (1 ± 5 and 10, above). However, while Ku gave intermediate shifts of probes, BRCTs of TopBP1 retained probes at the top of the gel in electrophoresis. This is not a`classical' observation and suggests formation of a very large DNA-protein complex. Consistently, the cross-linking experiment showed that proteins with BRCTs partly formed large complexes of more than 480 kDa independently of DNA fragments (Figure 7b) . Further, the smear retardation pattern suggests oligomeric or monomeric DNA-BRCT complex. Ku and BRCT are also dierent in their structures. The DNA-binding activity of Ku requires the heterodimerization of carboxyl-terminal 20 kDa of p70 and carboxyl-terminal 45 kDa of p86 (Wu and Lieber, 1996) . On the other hand, the primary structure of BRCT required for binding is only one region composed of about 100 amino acid residues (B1, B6 and B7 BRCTs).
We found that the BRCTs of BRCA1 also bound DNA termini (Figure 9 ). The binding features were very similar to those of TopBP1. BRCA1 localized at replication origins after DNA damage (Scully et al., 1997a) . We suggest that the localization may be a consequence of BRCT binding to damaged DNA, and that a protein with a BRCT mutated in Nijmegen breakage syndrome (Varon et al., 1998) may play a role in DNA break detection or repair with the BRCT. We expect that cell cycle checkpoint proteins, including Rad9 and Cut5/Rad4, detect DNA damage and ends of replicating DNA with their BRCTs. The yeast Cut5 protein, most similar to TopBP1, interacts with the Chk1 kinase (Saka et al., 1997) , which aects the Tyr15 phosphorylation state of the Cdc2 kinase through Cdc25 (for example, Furnari et al., 1997) . Since TopBP1 bound DNA ends directly, it is possible that TopBP1 and Cut5 directly detect DNA ends by the binding, linking to the Cdc2 kinase. Therefore, it is interesting to examine whether TopBP1 interacts with human Chk1. Our ®ndings give the concrete image of DNA damage detection since we showed the direct binding of the BRCTs to DNA breaks. It is necessary to determine whether other BRCTs can bind DNA breaks.
The binding patterns of several BRCT regions in TopBP1 showed proper preference to various DNA fragments (Figure 4 ). The B6 regions showed proper binding speci®city to DNA longer than 70 base pairs with weak binding eciency. The BRCT regions of TopBP1 did not bind intact circular DNA, indicating that binding to broken DNA was not non-speci®c aggregation ( Figure 5 ). Consistently, unlabeled circular DNA showed very weak inhibition of the binding of labeled circular DNA (Figure 6 ).
The BRCT-DNA complex showed resistance to an exonuclease, indicating that BRCT bound DNA breaks (Figures 7a and 9e) . We also digested the complex with an endonuclease, DNase I to perform footprinting analysis. The protection pattern ranged from ends to internal regions more than 2000 base pairs from the ends (data not shown), indicating that the DNA in a huge DNA-BRCT complex showed relative entire resistance to the endonuclease. Generation of new breaks by the endonuclease may relocate BRCTs. It should be noted that there are few successful footprinting experiments using DNA end binding proteins. The complex should be subjected to biophysical and other special analyses, over our standard biochemical analysis.
ATM (ataxia telangiectasia mutated, homologous to Rad3) is few DNA damage sensing elements known in human, although the sensing mechanism is poorly understood. Since the TopBP1 protein (homologous to Rad4/Cut5) is shown to bind DNA damage directly, this report proposes a novel, concrete damage-sensing model in human. In this context, this signi®cance may exceed that of ATM at present.
TopBP1 mRNA has 12 AUUUA motifs that can make mRNA unstable. The tailing patterns of TopBP1 transcripts indicated that the mRNAs were promptly degraded (Yamane et al., 1997) . Consistently, the TopBP1 protein was immediately degraded upon cell lysis, in spite of the addition of several protease inhibitors (Figure 8a ). Immunoprecipitation with antiTopBP1 antibody did not give bands, suggesting no stabilization with the antibody (data not shown). Further, forced expression using the cytomegalovirus promoter or the elongation factor 1 promoter gave only faint expression of the TopBP1 gene (data not shown).
We now propose a novel mechanism of tumorigenesis by tumor suppression release, judging from the association of BRCTs in major tumor suppressors (Introduction). A certain defect of proteins with limited BRCTs (Introduction, a ± d) would result in partial defects of DNA repair or cell cycle arrest after DNA damage. These states elevate mutation rates randomly, leading to the accumulation of mutations required for multistep carcinogenesis. This mutator hypothesis of tumorigenesis is dierent from transcriptional mechanism discussed in BRCA1 (Monteiro et al., 1996) and in Rb (Sherr, 1996) , although they may not be mutually exclusive. Another mutator hypothesis is already supported by reported evidence about the tumor suppressor Msh2, which is a mismatch repair protein frequently mutating in hereditary nonpolyposis colorectal cancer (HNPCC) (for example, Cranston et al., 1997) .
The BRCT binding protein of XRCC1 is DNA ligase III (Kubota et al., 1996) . This is symbolic since BRCT and the ligase are suggested to cooperate in DNA repair. The ligation frequently constitutes the ®nal step in DNA break repair. BRCT may play a bifunctional role of binding to both DNA breaks and proteins. Other BRCT binding proteins are Crb2, Crb3, Chk1 kinase (Saka et al., 1997) , and p53 (Thukral et al., 1994) . The major features of BRCTs are the amino-central Gly-Gly motif and the carboxylterminal Trp-(hydrophobic amino acid)-(hydrophobic amino acid) motif. The central motifs (Thr-His-Leu-Ile in TopBP1) are not well conserved, but are characteristic in part. It may be possible that the amino-central and the carboxyl-terminal motifs are important for general binding to DNA breaks, and the central motifs specify protein binding. It is interesting to examine this possibility and how the binding state changes when BRCT meets the DNA breaks. We predict that the binding proteins directly related to DNA repair will participate in the repair and that the binding proteins related to checkpoint signaling, such as Chk1, will dissociate from BRCT to transduce the damage signal.
Topoisomerase II introduces transient DNA breaks. This is one of the reasons why the molecule could be the major molecular target of cytotoxic anticancer drugs. Therefore, the association of TopBP1 with topoisomerase II (Figure 8b ) is reasonable to detect the DNA breaks caused by failure of the catalytic reactions of topoisomerase II. TopBP1 will have other important binding partners that are related to cell cycle checkpoints, to DNA repair, and to tumor suppression, remaining to be elucidated.
Materials and methods

Construction of GST fusion proteins
Primers (Biologica) to amplify genes coding for BRCT and other regions were listed below. 55-101: 5'-CCCGGGCCC-AAGAGCCGAACATCCAGTTTATAATATGGTTATG -3' 55-102: 5'-AATAGGACACTTGAAATCTTCCATGTTTA- '-CCCGGGCCAGT-CAGAGAAGGAAGAAGCCCCAAAGCC-3' 55-109: 5'-G- '-CTCGAGTCA-AGAGGGAAGCAAAATAGGTTTCTTCAGG-3' BR1-1: 5'-CCCGGGAGCTTCAACAGAAAGGGTCAACAAAAG-AATG-3' BR1-2: 5'-CCCGGGCCACCAAGGTCCAAAGC-GAGCAAGAGAATC-3' BR1-3: 5'-CTCGAGCTTTGGAC-CTTGGTGGTTTCTTCCATTGAC-3' BR1-4: 5'-CTCGAG-TCAGTAGTGGCTGTGGGGGATCTGGGG-3' The gene coding for the B1 BRCT region was ampli®ed by polymerase chain reaction using primers 55 ± 101 and 55 ± 102, with a plasmid coding for the region as a template (Yamane et al., 1997) . The ampli®ed fragment was cloned into pCR2.1 (Invitrogen) and was again cloned into pGEX-5X-1 (Pharmacia), using the SmaI site encoded in the 5' primer and XhoI encoded in pCR2.1 to construct the GST-B1 fusion gene. This same procedure was performed using primers 55 ± 101 and 55 ± 106 to construct GST-B12, primers 55 ± 108 and 55 ± 109 to construct GST-B6, primers 55 ± 104 and 55 ± 107 to construct GST-B7, and primers 55 ± 104 and 55 ± 105 to construct GST-B78, and primers 55 ± 201 and 55 ± 202 to construct GST-C1, and primers 55 ± 203 and 55 ± 204 to construct GST-C2, and primers 55 ± 101 and 55 ± 205 to construct GST-B1del. The GST-B6-78-(pK835-55G) was derived from a HeLa cDNA library (Yamane et al., 1997) .
The gene coding for the BA12 BRCT region of BRCA1 was ampli®ed by polymerase chain reaction using primers BR1-1 and BR1-4, with a cDNA mixture from placenta (Clontech) as templates. The ampli®ed regions were ®nally cloned into the SmaI ± XhoI site of pGEX-5X-1 to construct GST-BA12. This same procedure was performed using primers BR1-1 and BR1-3 to construct GST-BA1, primers BR1-2 and BR1-4 to construct GST-BA2.
All ampli®ed sequences were con®rmed by DNA sequencing.
Production and puri®cation of GST fusion proteins
To produce glutathione S-transferase (GST) fusion proteins, E. coli JM83 (Vieira and Messing, 1982) carrying a fusion gene was cultured until optical density of 600 nm reached 0.7. This culture was shaken in the presence of 0.34 mM isopropyl-b-D-thiogalactopyranoside (IPTG) in 500 ml of L broth for 3 ± 4 h at 378C. Collected cells were then sonicated in the 10 ml of lysis buer (10 mM Tris-HCl, pH 7.7, 0.5 M NaCl) containing 10 mg of phenylmethanesulfonyl¯uoride. After centrifugation, lysates were stored at 7208C.
Thawed lysate was incubated with glutathione sepharose 4B beads (150 ml of 50% slurry, Pharmacia) at 48C on a slowly rotating mixer for 10 min. The beads were washed three times with 1.5 ml of 10 mM Tris-HCl, pH 7.7, 2 M NaCl, 10 mM EDTA, 0.5% Nonidet P40 (buer C) and then washed with 10 mM Tris-HCl, pH 7.7, 1 mM EDTA, 0.5% Nonidet P40 (buer B). To quantify proteins, gel loading buer was directly added to the samples and boiled for 5 min. Proteins were subjected to 5 ± 20% gradient polyacrylamide gel electrophoresis, stained and quanti®ed with Coomassie blue R-250 as egg white lysozyme as a standard. For example, 10 mg of B1 fusion was puri®ed from 1.5 ml lysate by this procedure.
Preparation of labeled DNA fragments HPLC puri®ed oligonucleotides (10 ± 100 pmol), or plasmid DNA fragments used in a DNA binding assay were labeled with 10 ± 30 mCi g-32 P-ATP (3000 Ci/mmol) and 15 units of T4 polynucleotide kinase in the accompanying buer (Fermentas). Unincorporated labels were removed by gel ®ltration.
E. coli JM83 carrying pUC19 (Vieira and Messing, 1982) was grown on an L broth plate containing 50 mg/ml of ampicillin, transferred into 10 ml of labeling medium containing 0.2 g of (NH 4 ) 2 SO 4 , 25 mg of KCl and 25 mg of NaCl, 1 mg of thiamine, 1 mM MgSO 4 , 4% glucose, 50 mg/ml of ampicillin, pH 7.1, and shaken at 378C for 1 h. The culture was metabolically labeled with 0.5 mCi of [ 32 P]orthophosphate (320 TBq/mmol) and shaken at 378C for 1.5 h. All plasmid DNAs used were prepared by an alkali lysis method (Birnboim and Doly, 1979) and puri®ed with phenol treatment, RNase treatment, and polyethylene glycol precipitation.
Alternatively, plasmids prepared by the alkali lysis method were digested with restriction enzymes and treated with bacterial alkaline phosphatase, and labeled as described above. Circular DNA was prepared by ligation of these labeled DNA. Treatment with ligase was important to prepare circular DNA without damage.
DNA binding assay
Puri®ed proteins (Figure 1b ) on beads were washed twice with buer B or speci®c buers. The proteins (12 pmol) on beads (35 ml of 50% slurry) were incubated with DNA at the indicated concentrations at 378C for 10 min, with occasional mixing. The beads were washed three times with buer B. Proteinase K (1 ml of 10 mg/ml) was then added directly to samples and incubated for 15 min at 378C. We also tried to elute DNA bound to protein by adding of SDS and boiling, but only partial elution was observed, compared with proteinase digestion. Sample loading dye was added to the digest and loaded onto 7% polyacrylamide, 0.24% N, N'-methylenebisacrylamide non-denaturing gel in the TBE buer. The gel was analysed with FUJIX BAS 2000 image analyzer.
Gel retardation assay
Puri®ed GST-fusion protein on glutathione beads was incubated twice with 300 ml of 10 mM reduced glutathione, 50 mM Tris-HCl, pH 9.1, at room temperature for 10 min. After neutralization with 1 N HCl, eluted proteins (5 mg) were concentrated and were incubated with labeled DNA fragments (20 pg) for 10 min at 378C in 20 ml volume. Sample loading dye (2 ml, 50% glycerol, 16TBE, bromphenol blue, xylene cyanol) was added, and directly loaded onto the gel.
Exonuclease digestion
After DNA binding, and washing (DNA binding assay), sample volume was adjusted to 35 ml. Then, 35 ml of 0.25 unit of BAL31 (Takara), 2 mM Tris-HCl, pH 8.0, 60 mM NaCl, 1.2 mM MgCl 2 , 1.2 mM CaCl 2 , 0.1 mM EDTA was added and incubated for 10 min at 228C, and the reaction was stopped by adding of 10 ml of 250 mM EDTA. Samples were ethanol precipitated with carrier plasmid DNA, digested with proteinase K, as described above, and treated with phenolchloroform.
Titration of binding to labeled DNA
We performed the binding assay (46 pmol protein/sample) with the mixtures of probes and with a series of diluted unlabeled DNA at 50 ml total volume. The intensities of bands were quanti®ed with an image analyzer corrected with a series of diluted probes (1 ± 1/20 dilution). The binding constant K was determined as described (Blier et al., 1993 
Western blotting with anti-TopBP1 antibody
To generate anti-TopBP1 antibody, the EcoRV ± EcoRI fragment of pK835-55 coding for the B-78-region (Yamane et al., 1997) was ligated with the SmaI ± EcoRI fragment of pK721 carrying genes coding for the maltose-binding protein (MBP) and a histidine hexamer, (His) 6 , to construct pK869. The MBP-(His) 6 -B-78-fusion was overproduced in E. coli, puri®ed with a nickel anity column (Invitrogen), and injected into a rabbit (developed in Sawady technology). Immunized serum was subjected to anity puri®cation using the GST-B6-78-protein to remove anti-MBP-(His) 6 fractions.
HeLa cells were washed with phosphate-buered saline, and were treated with TCA (trichloroacetic acid), and immediately mixed well to denature almost proteins. Alternatively, the cells were washed, trypsinized, and suspended in 10 mM Tris-HCl, pH 7.7, 5 mM EDTA, 1 mM phenylmethanesulfonyl¯uoride, 5 mg/ml of pepstatin A, 19 mg/ml of aprotinin, 0.1 mM carbobenzoxy-L-Leucyl-LLeucyl-L-Leucinal. The cells were sonicated and the lysate was incubated on ice for 20 min and treated with TCA. Lysis with mild detergents and nuclear isolation in the presence of several protease inhibitors, followed by the TCA treatment, gave a result similar to this sonication method.
Ultraviolet light sensitivity in vivo
Anti-sense phosphorothioate oligodeoxynucleotides, (5'-ACACATCGCTGGTGGTGCATACAAAATATG-3', 5 mM) against TopBP1 were introduced into HeLa cells with lipofectin as recommended (Gibco). A scrambled control was 5'-ACTCATCCCTGGGGGTGTTTACTTTATATG-3'. After 2 days, the amount of TopBP1 was measured as described above. Another 3610 4 cells in a well of 24 well were exposed to 10 J/m 2 ultraviolet light (254 nm). Cell survival was determined after 3 days by trypan blue exclusion and expressed as a percentage of control cells (non con¯uent) at 100%. The experiments were performed in triplicate.
